Dianabol Cycle: Maximizing Gains Safely With Effective Strategies
A Practical Guide to Testosterone, Its Use & Alternatives
(For educational purposes only – do not rely on this for medical advice)
---
1. What is Testosterone?
- Hormone type: Steroid sex hormone from the androgen family.
- Produced by: Leydig cells in testes (men), ovaries and adrenal glands (women).
- Functions:
- Libido & erectile function
- Red blood cell production
- Bone density, mood regulation, cognition
---
2. When Is Testosterone Therapy Considered?
| Situation | Typical Criteria |
|---|---|
| Hypogonadism (low testosterone with symptoms) | <300 ng/dL and ≥2 symptoms (e.g., low libido, fatigue, depression) |
| Age‑related decline (late‑life "seniors") | >60 yr, symptomatic, normal labs but desire improvement |
| Andropause | Symptoms present, no contraindications |
> Important: Testosterone levels fluctuate; confirm with 2–3 measurements or a single morning sample if symptoms persist.
Key Contraindications
- Uncontrolled prostate cancer (or high PSA >10 ng/mL without oncologic evaluation)
- Untreated severe obstructive sleep apnea
- Active polycythemia (>50% hematocrit) unless managed
- Thrombocytopenia or bleeding disorders
4. How to Monitor Patients on Testosterone Therapy
| Parameter | Frequency | Goal / Threshold |
|---|---|---|
| Serum testosterone (morning) | Every 3–6 months initially; then annually if stable | 500–1000 ng/dL (17–35 nmol/L) |
| Hematocrit & hemoglobin | Every 3–6 months | <50% hematocrit, <18 g/dL hemoglobin |
| PSA | Every 6–12 months | >2.5 µg/L or a 25% rise from baseline triggers biopsy |
| Lipid panel | Annually | Monitor for changes due to testosterone therapy |
| Liver function tests | Annually (if on HRT) | ALT/AST within normal range |
---
4. Decision‑Tree Algorithm
START
|
|---Patient presents with erectile dysfunction
| |
| |---Take full history, perform physical exam, labs
| |
| |---Screen for cardiovascular risk factors
| |
| |---Assess psychosocial status
| |
| |---If organic cause suspected → Order Doppler ultrasound
|
|---Findings: Erectile dysfunction present?
|
|---Yes → Evaluate:
| - Vascular (ultrasound)
| - Hormonal
| - Neurological
| - Psychogenic
|
|---No → Reassess, consider other causes
|
|---Treatment decision
|
|---If organic cause confirmed → Initiate therapy
| (PDE5 inhibitor, lifestyle changes)
| Provide counseling on risks/benefits
|
|---If no clear cause or psychogenic → Consider psychotherapy
|
|---Follow-up
|
| - Monitor efficacy and side effects
| - Adjust treatment as needed
7. Summary
- No single "best" medication – the choice depends on patient‑specific factors (co‑morbidities, concurrent drugs, lifestyle).
- Evidence base: All PDE5 inhibitors are similarly effective; newer agents offer modest advantages in certain subgroups.
- Safety considerations: Avoid use with nitrates or strong CYP‑3A4 inhibitors; monitor for hypotension and visual disturbances.
- Cost and adherence: Generic sildenafil is the most economical but may require twice‑daily dosing; tadalafil’s once‑daily regimen can improve compliance.
- Future directions: Ongoing trials of non‑PDE5 treatments (guanylate cyclase stimulators, gene therapy) promise alternative options for patients who cannot tolerate current drugs.
